Clinical Trials

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)

Location:

Jacksonville,  FL,  Rochester,  MN

Trial status:

Open for Enrollment

Why is this study being done?

A randomized, controlled trial designed to demonstrate the safety and effectiveness of the experimental device to deliver pulmonary vein isolation as a treatment for symptomatic atrial fibrillation.

Who is eligible to participate?

Inclusion Criteria:

- 18 to 75 years.

- paroxysmal atrial fibrillation

- failure of at least one AAD

- others

Exclusion Criteria:

- overall good health as established by multiple criteria

Last updated: 04/25/2013

NCT ID:

NCT01456000